The Efficacy and Safety of Bivalirudin Versus Heparin in the Anticoagulation Therapy of Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Background: Bivalirudin is a direct thrombin inhibitor (DTI) that can be an alternative to unfractionated heparin (UFH). The efficacy and safety of bivalirudin in anticoagulation therapy in extracorporeal membrane oxygenation (ECMO) remain unknown.Methods: This study followed the preferred reporting...
Saved in:
Main Authors: | Min Ma (Author), Shichu Liang (Author), Jingbo Zhu (Author), Manyu Dai (Author), Zhuoran Jia (Author), He Huang (Author), Yong He (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Management of Bivalirudin Anticoagulation Therapy for Extracorporeal Membrane Oxygenation in Heparin-Induced Thrombocytopenia: A Case Report and a Systematic Review
by: Han Zhong, et al.
Published: (2020) -
Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis
by: Liyao Liu, et al.
Published: (2022) -
Management of Anticoagulation during Extracorporeal Membrane Oxygenation in Children
by: Madhuradhar Chegondi, et al.
Published: (2022) -
Novel Applications of Anticoagulation with Bivalirudin in Cardiac Surgery
by: R Pradeep Kumar, et al.
Published: (2020) -
Heparin Dosing Regimen Optimization in Veno-Arterial Extracorporeal Membrane Oxygenation: A Pharmacokinetic Analysis
by: Julien Lanoiselée, et al.
Published: (2024)